Neurocrine Biosciences Market Sentiment

Neurocrine Biosciences Inc

NBIXNASDAQ

Trade with Public

$138.94

-0.55-0.39%

가까이에: Sep 23, 5:00 PM EST

$137.17

-2.32-1.66%

프리마켓: 4:13 AM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Neurocrine Biosciences Market Sentiment

Market sentiment signals for Neurocrine Biosciences (NBIX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 6.5% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

26 analysts

Options Flow (P/C)

—

Avg Consensus PT

$200

+45.6%

Highest Price Target

$253

+84.4%

Citigroup

Lowest Price Target

$160

+16.6%

Wolfe Research

Short Interest

6.5%

Rising — Bearish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 11, 2026	Morgan Stanley	Jeffrey Hung—	+33.4%	$182 → $183	Maintained	Equal-Weight
Sep 8, 2026	RBC Capital	Brian Abrahams—	+44.3%	$198 → $198	Maintained	Outperform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+84.4%	$249 → $253	Maintained	Buy
Aug 13, 2026	Morgan Stanley	Jeffrey Hung—	+32.7%	$196 → $182	Maintained	Equal-Weight
Aug 3, 2026	Canaccord Genuity	Sumant Kulkarni—	+53.1%	$200 → $210	Maintained	Buy
Aug 3, 2026	Truist Securities	Danielle Brill—	+55.3%	$200 → $213	Maintained	Buy
Aug 3, 2026	Wedbush	Laura Chico—	+41.4%	$185 → $194	Maintained	Outperform
Jul 31, 2026	Citigroup	Yigal Nochomovitz—	+81.5%	$246 → $249	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	+44.3%	$195 → $198	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Jeffrey Hung—	+42.9%	$193 → $196	Maintained	Equal-Weight
Jul 31, 2026	TD Cowen	Phil Nadeau—	+60.4%	$200 → $220	Maintained	Buy
Jul 31, 2026	Piper Sandler	David Amsellem—	+53.1%	$207 → $210	Maintained	Overweight
Jul 31, 2026	Cantor Fitzgerald	Josh Schimmer—	+56.7%	$210 → $215	Maintained	Overweight
Jul 31, 2026	Guggenheim	Yatin Suneja—	+61.8%	$200 → $222	Maintained	Buy
Jul 31, 2026	Stifel	Paul Matteis—	+56.7%	$188 → $215	Maintained	Buy
Jul 31, 2026	Needham	Ami Fadia—	+48.7%	$200 → $204	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+45.8%	$175 → $200	Maintained	Buy
Jul 17, 2026	Wells Fargo	Mohit Bansal—	+45.8%	$175 → $200	Maintained	Overweight
Jul 13, 2026	Truist Securities	Danielle Brill—	+45.8%	$155 → $200	Maintained	Buy
Jul 13, 2026	BMO Capital	Evan Seigerman—	+23.9%	$144 → $170	Maintained	Market Perform
Jul 7, 2026	RBC Capital	Brian Abrahams—	+42.2%	$183 → $195	Maintained	Outperform
Jun 30, 2026	UBS	Ashwani Verma—	+51.6%	$182 → $208	Maintained	Buy
Jun 2, 2026	Goldman Sachs	Corinne Johnson—	+55.3%	$213	Reinstates	Buy
May 29, 2026	RBC Capital	Brian Abrahams—	+33.4%	$180 → $183	Maintained	Outperform
May 22, 2026	Bernstein	Jeffrey Walch—	+61.1%	$221	Initiate	Outperform